Jefferies Reiterates Buy Rating on AdaptHealth (AHCO) as Investor Day Points to 8% Organic Growth

Go back to Jefferies Reiterates Buy Rating on AdaptHealth (AHCO) as Investor Day Points to 8% Organic Growth

AdaptHealth (AHCO) PT Raised to $28 at Deutsche Bank

September 20, 2022 6:59 AM EDT

Deutsche Bank analyst Pito Chickering raised the price target on AdaptHealth (NASDAQ: AHCO) to $28.00 (from $26.00) while maintaining a Buy rating.... More

AdaptHealth (AHCO) PT Raised to $28 at Truist Securities

September 19, 2022 7:10 AM EDT

Truist Securities analyst David MacDonald raised the price target on AdaptHealth (NASDAQ: AHCO) to $28.00 (from $26.00) while maintaining a Buy rating.... More